Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 14Lymphoid 8CNS 4Plasma cell 3Myeloid 3Gastrointestinal 3Sarcoma 2Other solid neoplasm 2Head & Neck 2Gynecologic 2Genitourinary 2Dermatologic 2Breast 2Thoracic 1Classical hematology 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Blotting, Western × Thoracic × Clear all
NCT00897650 2017-07-19

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Vanderbilt-Ingram Cancer Center

Completed
204 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡